Zevra Therapeutics Inc (ZVRA)
9.13
+0.16
(+1.78%)
USD |
NASDAQ |
Nov 21, 16:00
9.145
+0.02
(+0.16%)
After-Hours: 20:00
Zevra Therapeutics Price to Book Value: 6.985 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 6.985 |
| November 20, 2024 | 6.862 |
| November 19, 2024 | 6.862 |
| November 18, 2024 | 6.579 |
| November 15, 2024 | 6.594 |
| November 14, 2024 | 6.908 |
| November 13, 2024 | 6.625 |
| November 12, 2024 | 6.556 |
| November 11, 2024 | 6.855 |
| November 08, 2024 | 6.885 |
| November 07, 2024 | 6.721 |
| November 06, 2024 | 6.721 |
| November 05, 2024 | 6.569 |
| November 04, 2024 | 6.523 |
| November 01, 2024 | 6.408 |
| October 31, 2024 | 6.218 |
| October 30, 2024 | 6.431 |
| October 29, 2024 | 6.302 |
| October 28, 2024 | 6.141 |
| October 25, 2024 | 5.912 |
| October 24, 2024 | 6.027 |
| October 23, 2024 | 6.111 |
| October 22, 2024 | 6.363 |
| October 21, 2024 | 6.515 |
| October 18, 2024 | 6.477 |
| Date | Value |
|---|---|
| October 17, 2024 | 6.508 |
| October 16, 2024 | 6.454 |
| October 15, 2024 | 6.393 |
| October 14, 2024 | 6.164 |
| October 11, 2024 | 6.225 |
| October 10, 2024 | 6.042 |
| October 09, 2024 | 6.462 |
| October 08, 2024 | 6.386 |
| October 07, 2024 | 5.943 |
| October 04, 2024 | 5.493 |
| October 03, 2024 | 5.478 |
| October 02, 2024 | 5.432 |
| October 01, 2024 | 5.226 |
| September 30, 2024 | 5.294 |
| September 27, 2024 | 11.21 |
| September 26, 2024 | 11.84 |
| September 25, 2024 | 12.22 |
| September 24, 2024 | 13.40 |
| September 23, 2024 | 12.28 |
| September 20, 2024 | 13.06 |
| September 19, 2024 | 12.99 |
| September 18, 2024 | 12.69 |
| September 17, 2024 | 12.20 |
| September 16, 2024 | 12.60 |
| September 13, 2024 | 12.72 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.139
Minimum
May 11 2022
13.40
Maximum
Sep 24 2024
3.284
Average
2.526
Median
Aug 22 2023
Price to Book Value Benchmarks
| Ionis Pharmaceuticals Inc | 8.090 |
| Vanda Pharmaceuticals Inc | 0.5322 |
| BioCardia Inc | 3.555 |
| Xeris Biopharma Holdings Inc | -- |
| Instil Bio Inc | 0.9163 |
Price to Book Value Related Metrics
| PS Ratio | 15.86 |
| PEG Ratio | -0.0172 |
| Price | 9.13 |
| Earnings Yield | -23.11% |
| Market Cap | 487.32M |
| PEGY Ratio | -0.0172 |